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ABSTRACT OF THE THESIS 
Frontotemporal Dementia Knowledge Scale: Development and Preliminary Psychometric 
Properties 
by 
Matthew John Wynn 
Master of Arts in Psychological and Brain Sciences 
Washington University in St. Louis, 2018 
Brian D. Carpenter, Chair 
Frontotemporal dementia (FTD) accounts for about 10 percent of dementia cases and is a 
common cause of early-onset dementia. Although knowledge about the symptoms and 
course of FTD has expanded in the past decade, there exists no well-validated instrument 
to measure FTD knowledge. As a step toward that goal, this study sought to create a scale 
to measure knowledge of FTD based on contemporary understanding of the disease. 
Standard scale development methods were used to create items, and their psychometric 
properties were evaluated in a sample of 174 healthcare providers and caregivers of 
people with FTD. The resulting scale (Frontotemporal Dementia Knowledge Scale; 
FTDKS) contains 18 items and takes approximately five minutes to complete. The 
FTDKS displays good psychometric properties in terms of reliability (internal 
consistency and split-half reliability) and validity (content, predictive, concurrent, 
convergent, and divergent) in the current sample. The FTDKS can be used with 
healthcare providers and caregivers of people with FTD to assess their knowledge in 
clinical care and program evaluation. Further research is needed to examine the 
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psychometric properties in more diverse samples and to evaluate its utility in educational 
initiatives.  
 
  
 
Frontotemporal dementia (FTD) refers to a group of disorders caused by progressive and 
selective degeneration of the frontal and temporal lobes of the brain (Pressman & Miller, 2014). 
As a group, the FTD family of syndromes accounts for approximately 10 percent of dementia 
cases, affecting 4.6 million people worldwide, with a prevalence of 15-22 per 100,000 (Bang, 
Spina, & Miller, 2015; Onyike & Diehl-Schmid, 2013). FTD is the third most prevalent cause of 
dementia and about as common as Alzheimer’s disease (AD) in terms of early-onset dementias 
(Bang et al., 2015; Lashley et al., 2015; Vieira et al., 2013). Approximately 60 percent of people 
with FTD are between the ages of 45 and 60 (Pressman & Miller, 2014). Knowledge about the 
symptoms and course of FTD has expanded in the past decade, both in terms of what we know 
and who knows it (Lashley et al., 2015; Nunnemann et al., 2012; Warren, Rohrer, & Rossor, 
2013), yet it remains unclear to what extent healthcare providers and caregivers of people with 
FTD are knowledgeable about the disease. Adequate knowledge about FTD is important for 
providers, as they are the main point of contact for early detection, diagnosis, and ongoing 
support (Shinagawa et al., 2016). Knowledge is also important among caregivers because they 
support patients with FTD in a myriad of ways (Küçükgüçlü et al., 2017; Lima-Silva et al., 
2015). Although educational resources exist to enhance knowledge about FTD (O’Connor, 2013; 
Ghoshal, 2018), to our knowledge there exist no empirical studies that examine what different 
groups know about the disease, and there are no instruments to measure FTD knowledge. The 
purpose of the current study was to create a scale to measure knowledge of FTD based on 
contemporary understanding of the prevalence, causes, symptoms, progression, and treatment of 
FTD. This new scale could be utilized in clinical care and to guide the development and 
evaluation of education initiatives. 
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 A crucial first step in FTD care management is timely and accurate diagnosis, and 
knowledge among providers plays an important role in allowing that to happen. In the United 
States, less than half of older adults living with dementia or their caregivers say that a physician 
has diagnosed them with dementia (Bradford et al., 2009; Connolly et al., 2011) and even fewer 
have a diagnosis of a dementing condition listed in their medical record (Chodosh et al., 2007; 
Riley McCarten et al., 2012). This situation may occur because some providers do not recognize 
the symptoms of dementia and lack other critical knowledge that could facilitate diagnosis. In the 
case of FTD, in order to make an accurate diagnosis, providers need to have an understanding of 
the heterogeneity of FTD presentation and progression. One person may exhibit early behavioral 
changes and progress rapidly, while another may struggle more with language disruption and 
decline gradually over a number of years. Identifying FTD as the cause underlying these 
different patterns of symptoms can be difficult for specialist and non-specialist providers alike, 
as evidenced in several studies. For example, one recent study conducted in an outpatient 
memory clinic tracked the clinical progression of 97 people with later confirmed FTD and found 
that nearly a quarter (22%) were not diagnosed with FTD while still alive (Landqvist Waldö et 
al., 2015). Furthermore, reviewing medical records (including relevant clinical records from 
other hospitals and general practitioners) in order to pinpoint symptom onset, only 14% of 
people with confirmed FTD received FTD as their first diagnosis, with the majority first 
diagnosed with a psychiatric disease, such as depression. The median time from symptom onset 
to first FTD diagnosis was four years, with some diagnoses taking as long as 15 years. The 
investigators hypothesized that providers may not be aware of the specific features of FTD and 
therefore are more prone to misdiagnosis.   
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Another study of people with FTD in an outpatient memory clinic found evidence of both 
missed diagnosis and misdiagnosis (Shinagawa et al., 2016). Of the 247 patients whose clinician 
referred them with a sole provisional diagnosis of behavioral variant FTD (bvFTD), 60% did not 
have bvFTD according to specialists. Conversely, of the 313 patients diagnosed with FTD by 
experts, 14% did not have any mention of FTD on their initial referral. False-positive and false-
negative diagnosis of FTD by non-specialist providers can have significant consequences, such 
as medication mismanagement for people with FTD and delay to resources for caregivers 
(Pressman & Miller, 2014; Warren et al., 2013). Therefore, educating physician providers about 
how to identify FTD accurately is an important public health effort.  
In addition, nonphysician providers such as psychologists, social workers, and nurses are 
receiving increasing attention for their role in the dementia diagnostic process (Maslow & 
Fortinski, 2018). These providers interact with older adults who have not had a formal evaluation 
but are showing signs of cognitive impairment, and they may be closely connected with 
caregivers and consequently in a position to assist with detection, diagnosis, and education about 
cognitive impairment. Recent dementia care guidelines advocate for training of nonphysician 
direct care providers so they can recognize the signs of dementia and understand when and how 
to communicate these changes to experts, people with dementia, and their families (Wiener et al., 
2016). Likewise, the U.S. Administration for Community Living (ACL), in its dementia-capable 
states and communities initiative, funded training for nonphysician staff and for professional care 
providers to help them identify persons with cognitive impairment and refer them for diagnosis 
and services (National Alzheimer’s and Dementia Resource Center, 2014). Knowledge of FTD, 
similar to the other dementias, among nonphysician professionals is important in order to help 
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patients and their families receive an accurate and timely diagnosis, as well as referrals to FTD-
specific resources.  
Knowledge about FTD is also important for the caregivers who support people with the 
disease. FTD caregivers experience high rates of stress and burden (Lima-Silva et al., 2015), 
higher than people caring for individuals with other types of dementia (Liu et al., 2017; Mioshi et 
al., 2009). Several features of the disease, such as personality changes, disinhibition, and 
language disruption, can make caregiving particularly challenging. Caregiving stress models 
(e.g., Pearlin et al., 1990) identify a lack of knowledge as contributing to stress and educational 
initiatives as moderating stress (Judge, Menne, & Whitlatch, 2010). Moreover, when asked about 
their needs, FTD caregivers highlight information about FTD symptoms, effective 
communication, and behavior management strategies as important (Diehl-Schmid et al., 2013). 
Despite the need for education, one review cited lack of knowledge and information regarding 
the disease as a major problem facing caregivers (Nunnemann et al., 2012). An FTD knowledge 
scale could be used to evaluate the benefit of educational interventions as learning tools. 
Moreover, it could be used to measure the relationship between disease-specific knowledge and 
caregiver stress, as well as to characterize the effect of educational interventions on caregiver 
quality of life and other outcomes.  
National and state organizations have undertaken efforts to increase detection of 
cognitive impairment and facilitate earlier and more accurate diagnosis, often by increasing 
providers’ knowledge of dementia (Comas-Herrera, et al., 2016; U.S. Department of Veterans 
Affairs, 2016). Similar initiatives specific to FTD will require tools to gauge knowledge of FTD 
among physicians, nonphysicians, and caregivers and to guide education efforts among these 
groups. To our knowledge, however, no studies have attempted to measure knowledge of FTD in 
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any systematic way, nor is there a well-validated tool with which to measure FTD knowledge. 
The purpose of this project was to create and validate a Frontotemporal Disease Knowledge 
Scale (FTDKS) to measure knowledge of FTD based on contemporary understanding of the 
disease. 
Method 
Development of FTDKS Items 
We developed an initial set of 38 scale items by reviewing the literature for information 
about frontotemporal dementia corresponding to several content domains. These content 
domains (risk factors, assessment and diagnosis, symptoms, course, life impact, treatment and 
management, caregiving) were adapted from similar scales measuring knowledge of Alzheimer’s 
disease (Annear et al., 2015; Carpenter et al., 2009) and were used as a framework for our 
literature search, ensuring content relevance and coverage. Informed by test development 
guidelines (DeVellis, 2016; Kline 2005; Streiner & Norman, 2016), the research team reviewed 
each item, removed those with overlapping content, and rewrote items for clarity. Despite our 
effort to create items easy to understand, disease-specific terms, which may be difficult to 
understand for some people, were present due to their importance to knowledge about FTD. The 
resulting Flesch-Kinkaid Grade Level reading score (Kincaid et al., 1975) of 11.8 corresponds to 
a twelfth-grade reading level. At the conclusion of this process, 27 potential items remained. 
The 27 items were reviewed by eight experts currently working in FTD clinical research 
(six physicians, one nurse practitioner, and one psychologist) who commented on accuracy, 
wording, and overall content coverage. Based on their feedback, three items were removed from 
the scale, seven were rewritten for clarity, and three new items were added in order to increase 
content coverage. Next, two groups, one consisting of community-dwelling older adults and the 
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other graduate students in clinical psychology (n = 5 in each group), reviewed the items to 
identify unclear phrasing. After each individual participant had answered all items, group 
members were asked to explain what they thought each item was asking and why they responded 
as they did. This “think-aloud” technique identified errors based on misunderstanding of the 
question and questions that were easily answered despite a lack of knowledge regarding FTD. At 
this phase, three items were removed from the scale and six were rewritten for clarity. The final 
scale contained 24 items. 
We adopted a 4-point Likert-type scale format, with an auxiliary “Don’t Know” option 
adapted from the Dementia Knowledge Assessment Scale (DKAS; Annear et al., 2015). 
Compared to a True/False response format, the 4-point scale plus Don’t Know detect a wider 
range of uncertainty about each item, which more precisely reflects knowledge (Annear et al., 
2016).  
 
 
Participants and Procedure 
To evaluate the final items we recruited medical professionals and caregivers of people 
with FTD to complete the scale, the types of people with whom the final version of the FTDKS 
might be used. Characteristics of the subsamples appear in Table 1. Providers were contacted 
through publicly available email addresses and snowball sampling. Primary care clinics, 
Alzheimer’s Disease Research Centers, and professional organization listservs were targeted to 
recruit providers from varying disciplines with varying degrees of knowledge about FTD. 
Providers were sent emails containing a brief description of the study and a link to participate via 
an online survey.  
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With the collaboration of the Association for Frontotemporal Degeneration (AFTD), 
caregivers were recruited from FTD support groups throughout the United States. Using publicly 
available email addresses, 95 support group leaders were contacted, with permission of the 
AFTD, and given email templates and flyers containing a brief description of the study and a link 
to participate in the online survey. Support group leaders then distributed these materials to 
members of their caregiver support group. Additional caregiver recruitment was conducted 
through postings on the AFTD’s Facebook page and the FTD Support Forum website. Given 
these methods of recruitment, it was not possible to know exactly how many emails were 
forwarded to providers and caregivers we did not contact directly, and thus it was not possible to 
calculate a final response rate. The online survey was hosted by Qualtrics, a secure, HIPAA-
compliant platform for collecting survey data (Qualtrics, Provo, UT).  
 
 
Measures 
Demographics and background. Demographic items inquired about gender identity, 
age, race, ethnicity, education, and occupation. Respondents also completed a series of questions 
to assess experience with FTD. These questions were tailored for providers versus caregivers and 
addressed practice setting, experience with FTD, current or previous FTD caregiving experience, 
where they had received information and education related to FTD, and self-rated knowledge of 
FTD (0 = “I’ve never heard of FTD” to 10 = “I am extremely knowledgeable about FTD”).  
Objective knowledge about FTD and dementia.  The Dementia Knowledge 
Assessment Scale (DKAS; Annear et al., 2015) was included as a measure of general dementia 
knowledge. The DKAS is a 25-item scale that uses a 4-point Likert-type scale (False, Probably 
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False, Probably True, True) with an auxiliary Don’t Know option. Item content covers causes 
and characteristics, communication and engagement care needs, and risk factors and health 
promotion. Scores can range from 0 to 50, with higher scores indicating more accurate 
knowledge about dementia. According to the original validation study, the DKAS has good 
internal consistency (Spearman-Brown correlation coefficient of 0.78; alpha of 0.86), and 
validity as a measure of dementia knowledge in a sample of health workers and students. The 
second knowledge scale, the FTDKS, was developed as described above.   
General intelligence. The Shipley Institute of Living Scale (Shipley, 1940) includes 40 
progressively difficult vocabulary words. Respondents choose which of four listed words “means 
the same or nearly the same” as a target word. The number of correct items is the final score, 
with possible scores ranging from 0 to 40. The Shipley has good test-retest reliability (median r 
= .78), internal consistency reliability (alpha = .80 in the current sample), validity as a measure 
of general intelligence (median r = .71 with more formal measures of IQ such as the WAIS), and 
the scale has been normed in a wide range of populations (Zachary, 1991).  
Analytic Plan 
 The aim of the current study was to assemble a set of items that had sufficient face 
validity and content coverage about FTD and a scale that had good reliability and validity. We 
used descriptive statistics to investigate the utility of the 4-point response scale with the “Don’t 
Know” option. Independent sample t-tests between provider and nonprovider group were used to 
examine possible differences in the use of scale response options. To aid with item selection we 
calculated the discrimination index and item difficulty index for each item. Internal consistency 
reliability was evaluated with Cronbach’s alpha (average interitem correlation), split-half 
reliability, and item-total correlations. Independent sample t-tests between provider and 
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nonprovider groups and correlations between FTDKS total score and independent variables were 
used to examine the predictive validity, convergent validity, concurrent validity, and divergent 
validity of the FTDKS.  
Results 
Sample Characteristics 
A small number of respondents (n = 4) were not medical professionals or did not know 
anyone with FTD and were therefore removed from analysis, leaving a final sample of 174. 
Respondents were grouped into two subsamples, providers and nonproviders, and their 
characteristics appear in Table 1. Providers were, on average, younger, t(171)= -7.17, p < .001, 
and more educated, 2(5) = 82.86, p < .001, but there were no differences between groups in 
terms of gender, 2(2) = 2.99, p = .224, race, 2(5) = 7.403, p = .116, or self-rated knowledge of 
FTD, t(172) = -.721, p = .472. The subsample of providers (n = 72) was comprised of 
experienced (53% with eight or more years of experience) and educated (71% with doctoral 
degrees) professionals from various disciplines, who had at least “some” experience treating, 
diagnosing, or managing the care of people with FTD. The subsample of nonproviders (n = 102) 
was made up of spouses, children, relatives, and friends, and professional caregivers of people 
with FTD, the large majority of whom identified as the primary caregiver (73%). 
Use of the Response Scale 
A 4-point response scale was chosen over a more conventional dichotomous True/False 
scale in order to increase precision. We calculated several descriptive statistics to examine 
whether respondents utilized the full range of response options. For example, one respondent did 
not vary in their use of the different response options (e.g., 100% of their responses were either 
“True” or “False” and 0% of their responses were “Probably True,” “Probably False,” or “Don’t 
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Know”), while other respondents made use of all response options. Respondents answered items 
with either “True” or “False” a majority of the time (M =  69.7%, SD = 20.5%, range = 0% - 
100%), followed next by “Probably True” and “Probably False”(M = 23.2%, SD = 16.9%, range 
= 0% - 83%), and used “Don’t Know” only occasionally (M = 7.11%, SD = 9.44%, range = 0% - 
46%). The use of different response options was also variable across items (see Table 2).  
Providers and caregivers did not significantly differ in their use of the certain and probable 
options, and providers were slightly less likely to use “Don’t Know” than caregivers, t(172) = -
3.88, p < .001. Overall, it appears that most respondents made use of the full range of the scale. 
Item Difficulty and Discrimination Indices 
Performance of individual items was examined to identify potential items for removal. 
Item difficulty and discrimination indices, described below and appearing in Table 2, are both 
helpful in identifying candidates for removal. First, percent correct (difficulty index; p) was 
calculated. Six items had difficulty indices above .95, indicating that at least 95% of respondents 
answered the item correctly. These items are unlikely to be useful in discriminating respondent 
knowledge due to their relative ease.  Next, discrimination indices were calculated for each item. 
The sample was divided into two groups based on their total FTDKS score, using cutoffs 
recommended by Kline (2005): 27% of the sample who scored lowest (n = 47) and 27% of the 
sample who scored highest (n = 48). Scores on the FTDKS ranged from 11 – 32 (M = 25.6, SD = 
5.82) for low scorers and 41 – 48 (M = 43.3, SD = 2.01) for high scorers. Individual item 
difficulty indices (p) were calculated for both low and high scorers. The difference of these 
indices (e.g., phigh-plow) is the discrimination index. A low percentage for the discrimination 
index (<10%; Kline, 2005) indicates that the item does not perform differently among the highest 
and lowest scoring respondents, suggesting that the item is not helpful in identifying respondents 
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with less versus more knowledge. Five items had a discrimination index below 10%, and these 
were five of the six items that had a difficulty index above 95%. The sixth item (“People with the 
behavioral variant of frontotemporal dementia often act on impulse instead of thinking things 
through.”) had a discrimination index of 11%. These six items included two about a FTD 
subtype (e.g., behavioral variant). Four different “subtype” items survived item analyses, so the 
poorly performing items were removed without losing core content. The other four items were 
more broad questions about course and progression and potentially represent core facts about 
FTD, but given their low difficulty and discriminability, these items were removed from the final 
scale, leaving 18 items.  
Properties of the 18-Item FTDKS 
On the 18-item FTDKS, the maximum score is 36. In this sample, scores on the FTDKS 
ranged from 5 to 36 (M = 24.2, SD = 6.70). 
Reliability. Internal consistency reliability (Cronbach’s alpha) was .806, indicating good 
internal consistency. Examining individual items, Cronbach’s alpha if an item were deleted 
ranged from .789 - .806, and the item-total correlations ranged from .230 - .513 (M = .392, SD = 
.075). Therefore, dropping items would not increase alpha substantially. Split-half reliability was 
calculated by randomly dividing the scale in half and correlating the items on the first and second 
halves, resulting in a Spearman-Brown coefficient of .792.   
 Validity. Correlations among knowledge indices and respondent characteristics are 
shown in Table 3. In terms of predictive validity, FTDKS Total Score should be significantly 
associated with variables related to knowledge of FTD. FTDKS Total Score was significantly, 
though modestly, correlated with self-rated FTD knowledge, r = .488, p < .001. This significant 
association was present within both provider, r = .57, p < .001, and nonprovider subsamples, r = 
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.47, p < .001. In terms of convergent validity, performance on the FTDKS should be significantly 
associated with performance on other scales that measure related constructs. The correlation 
between scores on the FTDKS and scores on the DKAS was .615, p < .001. The correlation 
between scores on the FTDKS and general intelligence as measured by the Shipley Vocabulary 
Test was .247, p <.05, as would be expected given that the two scales measure distinct 
constructs. In terms of concurrent validity, scores on the FTDKS should be significantly 
associated with people’s experience with FTD. Among providers, the FTDKS Total Score was 
significantly associated with experience treating people with FTD, r = .349, p < .01. Among 
nonproviders, FTDKS Total Score was significantly related to level of care provided to people 
with FTD, r = .231, p < .05. In an unexpected finding, an independent-samples t-tests revealed 
no significant difference on FTDKS performance between providers and nonproviders, t(172) = 
1.41, p = .160 (see Table 1 for means). In terms of divergent validity scores on the FTDKS 
should not be significantly associated with variables that do not necessarily relate to knowledge 
of FTD. Among providers, FTDKS Total Score was not significantly associated with general 
experience (years) as a provider, r = .167, p =.178. Among nonproviders, FTDKS Total Score 
was not significantly related to number of people with FTD known, r = .190, p = 0.05. 
Discussion 
This study establishes the reliability and validity of a new scale to measure knowledge 
about frontotemporal dementia, the Frontotemporal Dementia Knowledge Scale (FTDKS). The 
18-item scale is designed to be used with healthcare providers and caregivers of people with 
FTD. It covers general knowledge about FTD, including prevalence, symptoms, course, 
treatments, and caregiving. It can be administered in approximately five minutes and uses a 
response scale that enable respondents to indicate degrees of certainty about their knowledge. In 
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this validation study the scale had good psychometric attributes when evaluated in two samples, 
healthcare professionals with varying degrees of experience with FTD and individuals with FTD 
caregiving experience. The scale, along with a scoring key and documentation of answers, is 
available at http://pages.wustl.edu/geropsychology/ftdks. 
Although FTD is less common than Alzheimer’s disease, it is one of the most common 
forms of early-onset dementia, and people with FTD and their caregivers incur significant 
financial and emotional burden as a result of the disease (Warren et al., 2013). Timely diagnosis 
and appropriate care play a critical role in offsetting these costs, and knowledge of FTD among 
providers and caregivers increases the likelihood that patients will receive an early and accurate 
diagnosis and subsequent support. The FTDKS could be useful in documenting knowledge 
among providers and caregivers and could be utilized in steps to develop and evaluate 
educational initiatives for these groups.  
 Several limitations of the study should be noted. First, the scale was evaluated in only 
two subsamples, a group of FTD professionals and a group of individuals with FTD caregiving 
experience. We do not have evidence of how the scale would perform in other groups, such as 
people diagnosed with FTD or the general public. Additional research could verify the 
psychometric properties of the scale in other groups. Second, in a somewhat unexpected finding, 
we did not find a significant difference in FTDKS scores between our subsamples, indicating 
that, on average, providers and nonproviders were equally knowledgeable about FTD. It may be 
that because we recruited caregivers from AFTD support groups, they are especially involved 
and educated about the disease, with a level of knowledge equivalent to that of the providers. 
Future research with a broader sample, including caregivers of patients soon after diagnosis of 
FTD, highly specialized providers, and lay audiences will provide a clearer picture of how 
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different groups perform on this measure. Third, because the scale includes some technical 
language related to specific FTD facts, it is written at a fairly high grade level. As such, the scale 
may be less accessible among individuals with more limited literacy.  
 Fourth, in creating a scale to measure general knowledge of FTD that can be completed 
quickly, concerns about content coverage arose. In our initial pool of 24 items, six were 
answered correctly by almost all respondents. These items include two items about an FTD 
subtype (e.g., behavioral variant) and four items about general course and progression of the 
disease (see lower section of Table 2). We believe that the wording of the two FTD subtype 
questions may have been leading, which resulted in the high correct response rate despite the 
relatively deep knowledge required to identify the behavioral variant. In contrast, the other four 
general items potentially represent core facts about FTD that, while too easy for the current 
sample, may nonetheless represent basic common knowledge that could be used to gauge 
knowledge in a group that may be less familiar with the disease, such as community dwelling 
older adults or recently diagnosed patients and their caregivers. 
 Moreover, FTD refers to a group of clinical syndromes caused by frontotemporal lobar 
degeneration (FTLD), so a general scale about FTD will necessarily leave some specifics out. 
For example, items about some FTD subtypes, genetic risk factors, and the biological 
progression of the disease were not included because they were often too specific to have a 
universally accepted answer across the FTD spectrum. Different types of FTD progress at 
different rates, under different mechanisms, and with different symptoms and outcomes. Instead, 
the FTDKS includes items designed to reflect general knowledge of FTD, and the scale is not 
meant as an exhaustive measure of FTD. Likewise, as the scientific community continues to 
discover new facts and revise old ones regarding the disease, the FTDKS will require revision.  
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At the moment, however, the FTDKS is a reliable and valid scale of FTD knowledge across a 
range of domains relevant to healthcare provider and caregivers. 
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Table 1 
Characteristics of Respondents 
 
Total (n = 
174) 
Providers (n = 
72) 
Non-Providers (n = 
102) 
Characteristic M/n SD/% M/n SD/% M/n SD/% 
Age (years) 51.5 15.7 42.5 12.7 57.8 12.5 
Female 133 76.4 58 80.6 75 73.5 
White 157 90.2 60 83.3 97 95.1 
Education       
High School 5 2.9 0 0.0 5 4.9 
Some college 17 9.8 0 0.0 17 16.7 
Associate degree 7 4.0 3 4.2 4 3.9 
Bachelor’s degree 45 25.9 4 5.6 41 40.2 
Master’s degree 40 23.0 14 19.4 26 25.5 
Doctoral degree 60 34.5 51 70.8 9 8.8 
Professional experience with FTD       
None   4 5.6   
A little   17 23.6   
Some   18 25.0   
A lot   18 25.0   
Extensive   10 13.9   
Years of experience as a provider       
0-1   7 9.7   
2-4   15 20.8   
5-7   7 9.7   
8-10   7 9.7   
More than 10   31 43.1   
Professional discipline/specialty       
Geriatrician   13 18.1   
Primary care physician   2 2.8   
Psychologist   31 43.1   
  23 
Neurologist   5 6.9   
Registered nurse/Nurse 
practitioner 
  9 12.5   
Other   12 16.7   
Number of people with FTD known     5.20 1.78 
Level of care provided       
Never been involved in care     10 9.8 
Helped arrange for care     2 2.0 
Assisted in caregiving      16 15.7 
Primary caregiver     74 72.5 
FTDKS Total Score  24.1 6.70 25.0 5.47 23.5 7.40 
Self-rated FTD knowledge 7.07 1.79 6.96 1.78 7.16 1.80 
DKAS Total Score 35.9 6.94 40.3 6.36 35.3 6.84 
Shipley Institute of Living Scale 34.9 3.08 35.1 2.85 34.9 3.13 
Note. FTD = frontotemporal dementia; FTDKS = Frontotemporal Dementia Knowledge Scale; 
DKAS = Dementia Knowledge Assessment Scale. 
  
  
 
Table 2 
Item Characteristics of the Frontotemporal Dementia Knowledge Scale 
Item Statement True or 
False 
Probably 
True or 
False  
Don’t 
Know 
Difficulty 
Index (p) 
Discrimination 
Index 
Item-Total 
Correlation 
Alpha if 
item 
dropped 
1 Frontotemporal 
dementia is a type of 
Alzheimer disease. 
(F) 
 
89.33% 10.11% 0.56% 93.82% 19% .499 .793 
2 For the majority of 
people with 
frontotemporal 
dementia, symptoms 
appear before they 
are 65 years old. (T) 
 
71.35% 23.04% 5.62% 83.71% 32% .513 .789 
3 Among all people 
with dementia, 5-
10% of them have 
frontotemporal 
dementia. (F) 
 
40.45% 46.07% 13.48% 78.09% 36% .389 .796 
4 People in their 
thirties can develop 
symptoms of 
frontotemporal 
dementia. (T) 
 
71.34% 25.28% 3.37% 88.20% 30% .423 .795 
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5 Memory loss is a 
major symptom of 
frontotemporal 
dementia. (F) 
 
72.48% 26.97% 0.56% 72.47% 45% .435 .793 
6 Frontotemporal 
dementia can be 
passed down from 
parent to child. (T) 
 
63.48% 26.97% 9.55% 68.54% 55% .481 .790 
7 Among people under 
60 years old, 
frontotemporal 
dementia is about as 
common as 
Alzheimer disease. 
(T) 
 
43.26% 37.08% 19.66% 41.57% 48% .299 .802 
8 The results of a brain 
scan by itself can tell 
you whether a person 
has frontotemporal 
dementia. (F) 
 
69.67% 28.66% 1.69% 88.20% 23% .404 .796 
9 People with 
frontotemporal 
dementia do best 
when given choices 
among many options. 
(F) 
75.28% 19.66% 5.06% 87.08% 26% .331 .800 
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10 There are treatments 
to slow down 
frontotemporal 
dementia. (F) 
 
78.09% 21.35% 0.56% 92.70% 15% .432 .795 
11 After symptoms of 
frontotemporal 
dementia appear, the 
average life 
expectancy is 7 to 13 
years. (T) 
 
55.06% 38.20% 6.74% 82.02% 17% .298 .802 
12 Based on their age, 
people who are 70 
years old are more 
likely to develop 
frontotemporal 
dementia than people 
who are 50 years old. 
(F) 
 
57.31% 31.47% 11.24% 75.28% 45% .476 .791 
13 On average, 
caregivers of people 
with frontotemporal 
dementia report more 
stress than caregivers 
of people with other 
dementias. (T) 
 
48.88% 35.96% 15.17% 74.72% 45% .318 .801 
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14 Medications designed 
to improve memory 
and thinking in 
people with 
Alzheimer disease are 
also appropriate for 
people with 
frontotemporal 
dementia. (F) 
 
68.54% 22.48% 8.99% 86.52% 28% .395 .796 
15 The language variant 
of frontotemporal 
dementia is more 
common than the 
behavioral variant. 
(F) 
 
38.20% 29.22% 32.58% 55.06% 47% .336 .800 
16 People with the 
behavioral variant of 
frontotemporal 
dementia have 
difficulty 
remembering events 
from the past. (F) 
 
55.62% 34.27% 10.11% 68.54% 56% .391 .796 
17 People with the 
behavioral variant of 
frontotemporal 
dementia lack interest 
in things they used to 
find enjoyable. (T) 
 
61.24% 30.34% 8.43% 84.83% 28% .412 .795 
  28 
18 People with the 
language variant of 
frontotemporal 
dementia are able to 
read and write 
without difficulty. (F) 
62.36% 29.78% 7.87% 80.90% 17% .230 .806 
  Items removed from the final scale 
 
    
 Frontotemporal 
dementia is a disorder 
that causes a decline 
in a person’s 
behavior or language. 
(T) 
 
97.19% 2.25% 0.56% 99.44% 2%   
 There are different 
forms of 
frontotemporal 
dementia that lead to 
different major 
symptoms. (T) 
 
92.69% 7.30% 0.00% 96.63% 9%   
 After an initial period 
of decline, people 
with frontotemporal 
dementia do not 
experience further 
change in their 
symptoms. (T) 
 
93.26% 6.18% 0.56% 99.44% 2%   
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 When people with 
frontotemporal 
dementia act 
inappropriately, you 
can get them to stop 
by explaining why 
they should not do it. 
(F) 
 
85.95% 12.92% 1.12% 96.07% 9%   
 People with the 
behavioral variant of 
frontotemporal 
dementia often act on 
impulse instead of 
thinking things 
through. (T) 
 
89.32% 8.42% 2.25% 95.51% 11%   
 People with the 
language variant of 
frontotemporal 
dementia have 
difficulty in spoken 
conversations. (T) 
87.08% 10.11% 2.81% 97.19% 6%   
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Table 3 
Correlations Among Major Study Variables 
 1 2 3 4 5 6 7 8 
1. FTDKS –         
2. DKAS .615** –        
3. Self-Rated FTD Knowledge .488** .450** –      
4. Shipley Institute of Living Scale .247* .256* .075 –     
5. Professional experience with FTDa .349** .334 .634** -.036 –    
6. Years of experience as a providera .161 .530 .384** -.292 .327** –   
7. Level of care providedb .231* .085 .187  .086 - - –  
8. Number of people with FTD knownb .179 .213 .371**  .165 - - -.167 – 
Note. FTDKS = Frontotemporal Dementia Knowledge Scale; DKAS = Dementia Knowledge Assessment Scale; FTD = 
frontotemporal dementia. 
a Provider only 
b Non-provider only 
* p < 0.05. ** p < 0.01. 
